Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid
about
sameAs
Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysisAmnion-derived stem cells: in quest of clinical applications.Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).Ascitic complement system in ovarian cancerA Rational Strategy for the Use of Amniotic Epithelial Stem Cell Therapy for Liver Diseases.Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.Functional regeneration of irradiated salivary glands with human amniotic epithelial cells transplantation.Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line.Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
P2860
Q34306071-BE9B16DB-7EEA-4F97-B561-540A5680A89BQ35155196-D7131F59-88A9-4BA1-86CA-F3ED569F0EB7Q35677703-DE8DD33A-57A0-42C8-8767-DD0608790EF1Q35782339-9D89AA15-C6F9-4CED-96B0-E5B3298D2B67Q36616364-FD609630-4CD8-4B30-B6BE-5174C722619DQ36703057-14D522DA-C524-42B9-B503-8672675BA405Q36803615-A0B0B470-5D88-4A47-871F-2BEF0BA93CABQ37228809-95D39DDB-B08A-47C9-A5A7-551AFED4190AQ37372067-84D33FC6-62F1-41FF-B719-AC5A059EB7C1Q41292337-444305F6-C2F3-4D70-AF54-1C32619C87B5Q41809272-0D8CE8E3-4CAA-4504-ADB9-B71EE140BD2DQ46080553-70996874-81D1-4DD1-9571-E51D6E03E67B
P2860
Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Characterization of the membra ...... ic cells and in amniotic fluid
@ast
Characterization of the membra ...... ic cells and in amniotic fluid
@en
Characterization of the membra ...... ic cells and in amniotic fluid
@nl
type
label
Characterization of the membra ...... ic cells and in amniotic fluid
@ast
Characterization of the membra ...... ic cells and in amniotic fluid
@en
Characterization of the membra ...... ic cells and in amniotic fluid
@nl
prefLabel
Characterization of the membra ...... ic cells and in amniotic fluid
@ast
Characterization of the membra ...... ic cells and in amniotic fluid
@en
Characterization of the membra ...... ic cells and in amniotic fluid
@nl
P2860
P1433
P1476
Characterization of the membra ...... ic cells and in amniotic fluid
@en
P2093
B P Morgan
I A Rooney
P2860
P304
P407
P577
1992-08-01T00:00:00Z